Italia markets closed

ILMN Dec 2024 190.000 call

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
2,21000,0000 (0,00%)
In data: 03:10PM EDT. Mercato aperto.
Schermo intero
Chiusura precedente2,2100
Aperto7,6000
Denaro1,3500
Lettera2,4500
Prezzo d'esercizio190,00
Scadenza2024-12-20
Min-Max giorno2,2100 - 7,6000
Contratto - Min-MaxN/D
Volume1
Open Interest2
  • GlobeNewswire

    Myriad Genetics and Illumina Achieve Milestones in Strategic Partnership to Support Biopharma Clinical Trials

    Myriad can conduct prospective clinical trials using Illumina’s TruSight Oncology Comprehensive Investigational Use Only testSALT LAKE CITY, Sept. 19, 2023 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced two key milestones in its strategic partnership with Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, to advance and support clinical research for gene-based, targeted thera